Unlock all Features See Plans and Pricing

Serving leading biopharmaceutical companies globally:

Last Updated: January 19, 2022

DrugPatentWatch Database Preview

Investigational Drug Information for Lersivirine

Email this page to a colleague

« Back to Dashboard

What is the drug development status for Lersivirine?

Lersivirine is an investigational drug.

There have been 9 clinical trials for Lersivirine. The most recent clinical trial was a Phase 1 trial, which was initiated on February 1^st 2011.

The most common disease conditions in clinical trials are Infections and [disabled in preview]. The leading clinical trial sponsors are Pfizer, ViiV Healthcare, and [disabled in preview].

Summary for Lersivirine

US Patents	0
International Patents	0
US Patent Applications	223
WIPO Patent Applications	156
Japanese Patent Applications	30
Clinical Trial Progress	Phase 1 (2011-02-01)
Vendors	46

Recent Clinical Trials for Lersivirine

Title	Sponsor	Phase
Study to Estimate the Pharmacokinetics, Bioavailability and Effect of Food on Single Dose Modified-release Lersivirine 500 mg in Healthy Subjects	ViiV Healthcare	Phase 1
Study to Estimate the Pharmacokinetics, Bioavailability and Effect of Food on Single Dose Modified-release Lersivirine 500 mg in Healthy Subjects	Pfizer	Phase 1
A Long Term Safety Study Of Lersivirine For The Treatment Of HIV-1 Infection In Subjects Who Have Completed Treatment With Lersivirine In Studies A5271015 And A5271022	ViiV Healthcare	Phase 2

See all Lersivirine clinical trials

Clinical Trial Summary for Lersivirine

Top disease conditions for Lersivirine

Top clinical trial sponsors for Lersivirine

See all Lersivirine clinical trials

US Patents for Lersivirine

+ Get email alerts for changes to this table

Subscribe to access the full database, or Try it Free
Drugname	Patent Number	Patent Title	Patent Assignee	Estimated Expiration
>Drugname	>Patent Number	>Patent Title	>Patent Assignee	>Estimated Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Boehringer Ingelheim

Medtronic

Moodys

Harvard Business School

Express Scripts

Baxter

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.